StonvexLoading…
StonvexStonvexStonvexCore line items from SITM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $113.57M | $326.66M | $213.38M | $129.81M |
Operating Income | $-12.34M | $-66.98M | $-68.74M | $-52.72M |
Net Income | $-5.22M | $-42.90M | $-52.07M | $-44.06M |
EPS (Diluted) | $-0.20 | $-1.72 | $-2.12 | $-1.85 |
Total Assets | $1.29B | $1.29B | $1.28B | $1.27B |
Total Liabilities | $133.88M | $138.52M | $173.60M | $168.46M |
Cash & Equivalents | $498.48M | $16.76M | $27.11M | $172.52M |
Free Cash Flow OCF − CapEx | $17.87M | $35.13M | $22.14M | $-4.17M |
Shares Outstanding | 26.40M | 26.30M | 26.10M | 26.00M |